The journal of medical pharmaceutical and allied sciences (JMPAS) is committed to maintaining the highest standards of publication ethics and takes all allegations of research misconduct seriously, including but not limited to plagiarism, data fabrication, data falsification, citation manipulation, and unethical research practices. All submissions are subject to initial screening and, where necessary, further investigation in accordance with established ethical guidelines such as those of the Committee on Publication Ethics (COPE). When allegations arise, the journal will conduct a fair and confidential review, which may involve contacting the authors, reviewers, and relevant institutions for clarification. If misconduct is confirmed, appropriate actions will be taken, including rejection of the manuscript, publication of corrections or retractions, and notification to affiliated institutions or authorities where necessary. The journal is committed to ensuring transparency, integrity, and accountability throughout the investigation and resolution process.